-
Signature
-
Brett Sandercock, Chief Financial Officer
-
Issuer symbol
-
RMD
-
Transactions as of
-
22 May 2025
-
Transactions value $
-
-$891,286
-
Form type
-
4
-
Filing time
-
27 May 2025, 10:24:06 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Sandercock Brett |
Chief Financial Officer |
RESMED INC., 9001 SPECTRUM CENTER BLVD., SAN DIEGO |
Brett Sandercock, Chief Financial Officer |
23 May 2025 |
0001346064 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
RMD |
ResMed Common Stock |
Sale |
-$891,285 |
-3,644 |
-4.1% |
$244.59 |
86,283 |
22 May 2025 |
Direct |
F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: